About Xeris pharmaceuticals, inc.
Xeris Pharmaceuticals, Inc. is a leading pharmaceutical company that specializes in developing and commercializing innovative formulations of injectable drugs. The company's mission is to provide patients with ready-to-use, liquid-stable injectables that eliminate the need for complicated reconstitution processes and reduce the risk of medication errors.
Xeris' proprietary formulation technology has revolutionized the way injectable drugs are delivered to patients. By creating stable, pre-mixed solutions that can be administered without any additional preparation or dilution, Xeris has eliminated many of the challenges associated with traditional injectables.
One of Xeris' most significant contributions to the field of medicine is its development of Gvoke® (glucagon injection), a life-saving treatment for severe hypoglycemia in people with diabetes. Gvoke® is a prefilled syringe that contains a stable liquid formulation of glucagon, which can be easily administered by caregivers or even self-administered by patients themselves.
In addition to Gvoke®, Xeris has also developed several other innovative products using its proprietary formulation technology. These include Ogluo™ (glucagon nasal powder), which provides an alternative delivery method for glucagon that does not require injection; XP-0863 (diazepam nasal spray), a potential treatment for acute repetitive seizures; and XP-0656 (pramlintide insulin co-formulation), an investigational product designed to improve glycemic control in people with type 1 diabetes.
Xeris' commitment to innovation extends beyond its product portfolio. The company also invests heavily in research and development, exploring new ways to improve drug delivery and patient outcomes. Its team includes some of the brightest minds in pharmaceutical science, who work tirelessly to develop new solutions for unmet medical needs.
At Xeris Pharmaceuticals, patient safety and satisfaction are top priorities. The company's products undergo rigorous testing and quality control measures before they are released into the market, ensuring that patients receive safe and effective treatments every time.
Overall, Xeris Pharmaceuticals is an industry leader in developing innovative formulations of injectable drugs that make life easier for both healthcare providers and patients alike. With its cutting-edge technology and unwavering commitment to excellence, it's no wonder why Xeris continues to be at the forefront of pharmaceutical innovation today.